Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 805 of 6351
-
Simple malaria test in early pregnancy could save newborns
Prevention OngoingThe purpose of the INTREPiD study is to compare 1st trimester screening for malaria parasites with a high-sensitivity malaria rapid diagnostic test followed by treatment of test-positive women with artemether-lumefantrine (AL) against usual antenatal care on a composite adverse p…
Phase 4 • Sponsor: Duke University • Aim: Prevention
Last updated Jun 27, 2026 12:31 UTC
-
New hope for kids with severe colitis: oral drug trial launches
Disease control OngoingUlcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon (large intestine). This study will assess how safe and effective Upadacitinib is in treating pediatric participants with UC. Adverse event…
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Engineered immune cells get a metabolic boost to fight blood cancers
Disease control Recruiting nowThis is a single-center, nonrandomized, open-label dose-escalation study followed by dose-expansion of CD19- CD34t metabolically programmed CAR T-cell therapy in adult patients with relapsed or refractory CD19 B-cell non-Hodgkin lymphoma (NHL) or chronic lymphocytic leukemia (CLL…
Phase 1/2 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Can a common anesthetic protect young brains during heart surgery?
Disease control Recruiting nowThe study is devoted to the use of ketamine infusion in a subanesthetic dose in the postoperative period in children after surgical correction of congenital heart defects in children.
Sponsor: Kemerovo State Medical University • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New combo therapy shows promise for rare chest cancer
Disease control Recruiting nowThe aims of this study are to verify the feasibility, effectiveness, and safety of the combination of enrolizumab and radiotherapy for neoadjuvant treatment for locally advanced thymic carcinoma, and to provide recommendations for the establishment of unified evaluation criteria …
Phase 2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New combo therapy targets liver cancer in clinical trial
Disease control OngoingThe objective of the ROWAN clinical study is to assess the efficacy of local tumor control in HCC patients who receive TheraSphere followed by durvalumab and tremelimumab.
Phase 2 • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Virus injection takes on deadly brain tumor in new trial
Disease control Recruiting nowThis clinical trial aims to evaluate whether an oncolytic viral agent can treat recurrent glioblastoma. It will also assess the safety and tolerability of the oncolytic viral agent. The primary question it seeks to answer is: What medical problems do participants experience when …
Phase 1/2 • Sponsor: Mianyang Central Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New study tests common antidepressant for PTSD in military and civilian groups
Symptom relief PausedThis is a Phase 2 randomized, double-blinded, placebo-controlled study that will evaluate multiple potential pharmacotherapeutic interventions for PTSD utilizing an adaptive platform trial design. Participants are randomized among the available cohorts in the study and the result…
Phase 2 • Sponsor: Global Coalition for Adaptive Research • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
New pill aims to steady shaking hands in essential tremor trial
Symptom relief OngoingThe goal of this clinical study is to compare ulixacaltamide and placebo treatment in essential tremor. The main question it aims to answer is: • Is ulixacaltamide a safe and efficacious treatment for patients with essential tremor? Participants will be asked to participate in …
Phase 3 • Sponsor: Praxis Precision Medicines • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
Could gut bacteria help fight prostate cancer? new trial tests antibiotic combo
Disease control Recruiting nowPROMIZE is an open-label, multi-centre, single-arm, Phase I/II clinical trial, evaluating the safety, tolerability and anti-tumuor efficacy of an antibiotic combination and enzalutamide in patients with metastatic castration-resistant prostate cancer (mCRPC).
Phase 1/2 • Sponsor: Institute of Cancer Research, United Kingdom • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New pill takes on brain tumors and metastases in early trial
Disease control Recruiting nowThis multi-site, Phase 1/2 clinical trial is an open-label study to identify the safety, pharmacokinetics, and efficacy of a repeated dose regimen of NEO212 alone for the treatment of patients with radiographically-confirmed progression of Astrocytoma IDH- mutant, Glioblastoma ID…
Phase 1/2 • Sponsor: Neonc Technologies, Inc. • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Immunotherapy combo shows promise in colorectal cancer fight
Disease control Recruiting nowThe goal of this clinical trial is to compare the efficacy and safety of the combination of immune checkpoint inhibitors (ICIs) and FOLFOX regimen compared to FOLFOX regimen alone in the neoadjuvant chemotherapy of locally advanced colorectal cancer. The main question aims to ans…
Phase 2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Mass malaria treatment trial aims to wipe out hidden infections in ghanaian communities
Disease control Recruiting nowPrevious malaria control studies in Ghana have shown that community-wide approaches can substantially reduce malaria infections. In a mass testing, treatment and tracking (MTTT) study, more than 75% of people in target communities were reached, leading to a 24% reduction in asymp…
Sponsor: Noguchi Memorial Institute for Medical Research • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Can a One-Hour chat help teens at risk for suicide?
Symptom relief CompletedThe current study is a clinical trial, meaning a research study in which human subjects are prospectively assigned to one or more interventions to evaluate the effects of those interventions on health-related behavioral outcomes. Specifically, male and female adolescents with cur…
Sponsor: Ohio State University • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Stem cell mobilization offers new hope for uterine scarring and infertility
Disease control Recruiting nowThis study will assess the use of autologous bone marrow stem cells mobilization using 1,1'-\[1,4-phenylenebis-(methylene)\]-bis-1,4,8,11-tetraazacyclotetradecane (PLERIXAFOR) as an effective medical therapy for the treatment of Asherman's Syndrome (AS), Atrophic Endometrium (AE)…
Early phase 1 • Sponsor: Hugh Taylor • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Promising new eye treatment could halt vision loss from keratoconus
Disease control CompletedA Multicenter, Randomized, Double-Masked, Sham-Controlled, Parallel-Group Phase 3 Study to Evaluate the Efficacy and Safety of Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus
Phase 3 • Sponsor: Epion Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Can we unlock the secrets to stroke prevention in africa?
Knowledge-focused Recruiting nowStroke is increasing in low-income countries in Africa, and knowledge is lacking on risk factors and how to prevent stroke as well as how to best use the resources for rehabilitation after stroke which are very limited. Knowledge generation within this area is therefore urgently …
Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
New 'Four-in-One' antibody takes on tough lymphoma
Disease control Recruiting nowPhase I main objectives: To observe the safety and preliminary efficacy of GNC-035 in patients with relapsed/refractory non-Hodgkin lymphoma and other hematological malignancies, to determine the DLT and MTD, or MAD, and to determine RP2D. Phase II Main objective: To explore the …
Phase 1/2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Can a tiny scope make back surgery less invasive?
Disease control CompletedCurrently, microscopic discectomy is performed as a minimally invasive surgery, thus reducing impact of so-called conventional "open" discectomies. Although more technically demanding, discectomy with full endoscopy made possible a significant reduction of surgery invasive impac…
Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Can a single scan reveal hidden amyloid deposits across the body?
Diagnosis Recruiting nowTo evaluate the potential usefulness of 18F-92/AV45/TPZA/FT8, 11C-PIB positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various Pan-Amyloid-related disease patients.
Sponsor: Tianjin Medical University • Aim: Diagnosis
Last updated Sep 10, 2026 00:00 UTC